Prediction of Targeted Therapy Efficacy in EGFR-mutant Lung Cancer Patients Using AI-based Multimodal Data

Conditions

• Lung Cancer (NSCLC)
• EGFR Activating Mutation
• Adenocarcinoma Lung
• Postoperative Adjuvant Therapy

Interventions

• DIAGNOSTIC_TEST: Comprehensive analysis through laboratory tests, imaging techniques, and clinical data

Sponsor

Union Hospital, Tongji Medical College, Huazhong University of Science and Technology